Your browser doesn't support javascript.
loading
MTNR1B Gene Polymorphisms Are Associated With the Therapeutic Responses to Repaglinide in Chinese Patients With Type 2 Diabetes Mellitus.
Wang, Tao; Wang, Xiao-Tong; Lai, Ran; Ling, Hong-Wei; Zhang, Fan; Lu, Qian; Lv, Dong-Mei; Yin, Xiao-Xing.
Afiliação
  • Wang T; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China.
  • Wang XT; Department of Pharmacy, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Lai R; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China.
  • Ling HW; Department of Pharmacy, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Zhang F; Department of Endocrinology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Lu Q; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China.
  • Lv DM; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China.
  • Yin XX; Department of Pharmacy, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Front Pharmacol ; 10: 1318, 2019.
Article em En | MEDLINE | ID: mdl-31787898
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Suíça